Previous product
Back to products
Polivy (polatuzumab vedotin-piiq)
CHF19,110.00
Next product
Tibsovo (ivosidenib)
CHF38,438.32
Inrebic (fedratinib)
CHF6,421.16
Inrebic (fedratinib) is a medication used for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.
This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.
Category: Oncology
Reviews
There are no reviews yet.